Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that activate the immune system, aiming at enhancing antitumor immunity. Their clinical efficacy is well-documented, but the side effects associated with their use are still under investigation. These drugs cause several immune-related ad...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Int J Mol Sci
Главные авторы: Melissaropoulos, Konstantinos, Klavdianou, Kalliopi, Filippopoulou, Alexandra, Kalofonou, Fotini, Kalofonos, Haralabos, Daoussis, Dimitrios
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2020
Предметы:
Review
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7247001/
https://ncbi.nlm.nih.gov/pubmed/32403289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21093389
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы